先天性肾上腺皮质增生症终身住院模式与结局的人群队列研究
基于瑞士全国住院数据(2011-2022)的回顾性队列研究,比较先天性肾上腺皮质增生症(CAH)患者与其他住院者的住院特征与结局。共纳入12,569,835次住院,其中2,020次涉及CAH患者。CAH患者住院发生率在新生儿和婴儿及幼儿期最高,内分泌代谢疾病是各年龄组主要入院原因,且CAH与更高的合并症负担和严重院内结局风险相关。
要点
- CAH患者住院高峰在新生儿和婴儿及幼儿期,而对照组住院率随年龄增加。
- 内分泌代谢疾病是CAH患者各年龄组首位入院原因,成人期OR为2.61。
- CAH患者终身合并症负担更高,ICU入住风险增加(OR 1.55)。
核心结论
- CAH患者在所有年龄组均更早出现更复杂的住院,且严重院内结局风险更高,尤其在生命早期。
研究设计与样本
- 基于瑞士全国住院数据(2011-2022)的回顾性人群队列研究,共分析12,569,835次住院,其中2,020次涉及CAH患者。
- 按年龄分层为新生儿和婴儿、幼儿、儿童和青少年、成人,比较CAH住院与非CAH住院的结局。
主要发现
- CAH患者住院发生率在新生儿和婴儿及幼儿期最高,而对照组住院率随年龄增加。
- 内分泌代谢疾病是各年龄组主要入院原因(新生儿和婴儿OR 66.5 [95% CI, 8.88-498.07];幼儿OR 21.42 [95% CI, 4.67-98.20];儿童和青少年OR 53.32 [95% CI, 7.08-401.72];成人OR 2.61 [95% CI, 1.53-4.46])。
- CAH患者终身合并症负担更高(出生时每次住院平均5.5个诊断,对照组约60岁时才达类似负担)。
- CAH与严重院内结局风险增加相关,包括ICU入住(OR 1.55 [95% CI, 1.20-2.01]),差异在新生儿/婴儿中最大。
临床怎么用
- 对CAH患者应提高警惕,尤其在生命早期,并制定年龄特异性管理策略以应对住院和严重结局风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Congenital adrenal hyperplasia (CAH) is associated with lifelong risk of adrenal crises and increased cardiometabolic morbidity. However, population-level data on hospitalization patterns across the lifespan are limited. METHODS: In this population-based retrospective cohort study, we used nationwide Swiss hospital data (2011-2022). Hospitalizations with CAH (ICD-10-GM E25) were compared with all other hospitalizations without CAH. Outcomes included hospitalization incidence, main reasons for admission, number of diagnoses per hospitalization, and in-hospital outcomes. Analyses were stratified into neonates and infants, young children, children and adolescents, and adults. RESULTS: Among 12,569,835 hospitalizations, 2,020 involved individuals with CAH. Hospitalization incidence in CAH was highest in neonates and infants and young children, whereas in the control group it increased with age. Endocrine and metabolic disorders were the leading causes of admission across all age groups (neonates and infants: OR 66.5 [95% CI, 8.88-498.07]; young children: OR 21.42 [95% CI, 4.67-98.20]; children and adolescents: OR 53.32 [95% CI, 7.08-401.72]; adults: OR 2.61 [95% CI, 1.53-4.46]). Individuals with CAH had a substantially higher comorbidity burden across the lifespan (mean 5.5 diagnoses per hospitalization at birth versus similar burden only around age 60 in the control group). CAH was associated with an increased risk of severe in-hospital outcomes, including intensive care unit admission (OR 1.55 [95% CI, 1.20-2.01]), with the largest differences in neonates/infants. CONCLUSIONS: Across all age groups, CAH is associated with earlier and more complex hospitalizations and higher risk of severe in-hospital outcomes than in control groups, particularly in early life. These findings support the need for heightened awareness and age-specific management strategies.
引用
- Hafner L, Laager R, Mueller B, et al. Hospitalizations and outcomes in Congenital Adrenal Hyperplasia across the lifespan: A population-based cohort study. J Clin Endocrinol Metab. 2026. PMID: 42711746. doi:10.1210/clinem/dgag368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。